Class 2 medicine recallHigh riskMedicine · 7 Jul 2025
Laboratoires Théa trading as Thea Pharmaceuticals Limited have notified the MHRA of an out of specification event related to environmental monitoring during manufacturing, which may increase the risk of microbial contamination of the medicinal…

Class 2 medicine recallHigh riskMedicine · 25 Jun 2025
A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total…

Class 2 medicine recallHigh riskMedicine · 12 Jun 2025
Maxearn Limited have informed the MHRA that the carton used to package two imported batches of Inhixa have been released to the market with a typographical error on one side of the carton.
Class 2 medicine recallHigh riskMedicine · 9 Jun 2025
Chelonia Healthcare Limited is recalling specific batches of Paracetamol 500mg Tablets (100 pots) as a precautionary measure due to contamination following a small number of complaints of discoloured tablets within the pots.
Class 2 medicine recallHigh riskMedicine · 22 May 2025
Aspen Pharma Trading Limited is recalling a specific batch of Mercaptopurine 50mg tablets as a precautionary measure due to microbial contamination following a small number of complaints of discoloured tablets within the packs, identified…
Class 2 medicine recallHigh riskMedicine · 19 May 2025
Becton Dickinson UK Ltd has informed the MHRA that some units exhibit an open seal on the packaging of the applicator. This defect could increase the risk of the applicator device being contaminated with…

Class 2 medicine recallHigh riskMedicine · 17 Apr 2025
Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch…
Class 2 medicine recallHigh riskMedicine · 8 Apr 2025
It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of 2ppm. Reig Jofre UK…
Class 2 medicine recallHigh riskMedicine · 1 Apr 2025
Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for certain batches of Utrogestan Vaginal 200 mg Capsules. The carton label references ‘micrograms’ where it should…

Class 2 medicine recallHigh riskMedicine · 4 Mar 2025
Aspar Pharmaceuticals Limited have informed the MHRA of an error related to a batch of Boots Paracetamol 500 mg tablets (16s). The foil blister inside the carton incorrectly states ‘Aspirin 300 mg Dispersible Tablets’.…
Class 2 medicine recallHigh riskMedicine · 4 Mar 2025
Sun Pharmaceutical Industries Europe B.V. is recalling those product batches listed in this notification as a precautionary measure due to out of specification results reported for the Particulate Matter Test (PMT) during stability testing.

Class 2 medicine recallHigh riskMedicine · 5 Feb 2025
CNX Therapeutics is recalling the batches listed in this notification as a precautionary measure due to a small number of packs that contain an additional tablet of Nitrofurantoin. The registered product is a capsule…
Class 2 medicine recallHigh riskMedicine · 30 Jan 2025
Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination.
Class 2 medicine recallHigh riskMedicine · 22 Jan 2025
Bells Healthcare is recalling the listed batches of dextromethorphan hydrobromide BP containing products as a precautionary measure, due to foreign material detected in some bottles.
Class 2 medicine recallHigh riskMedicine · 9 Dec 2024
Wockhardt UK Limited is recalling this batch as a precautionary measure following the identification of a low number of units which may have a defect in the 'top case' resulting in a dose not…
Class 2 medicine recallHigh riskMedicine · 29 Oct 2024
Tillomed Laboratories Limited is recalling one batch of Labetalol 200mg Tablets as a precautionary measure due to potential mix-up at the manufacturing site.
Class 2 medicine recallHigh riskMedicine · 23 Oct 2024
Bristol Laboratories Ltd. are recalling one batch of Phenobarbital Bristol Labs 15mg Tablets as a precautionary measure due to the potential of contamination of small metallic particles within the tablets.
Class 2 medicine recallHigh riskMedicine · 30 Sep 2024
Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies.
Class 2 medicine recallHigh riskMedicine · 15 Aug 2024
Strides Pharma UK Ltd is recalling the listed batch as a precautionary measure due to an out of specification result for microbial contamination, reported during retesting.
Class 2 medicine recallHigh riskMedicine · 22 Jul 2024
Glaxo Wellcome UK Ltd (GSK) has informed the MHRA that vials of Flolan 1.5 mg Powder and Solvent for Solution for Infusion, batch number AB8M may have been damaged during the packaging process.
Class 2 medicine recallHigh riskMedicine · 16 Jul 2024
Sun Pharmaceutical Industries Europe B.V. is recalling the listed batches as a precautionary measure due to visible particulate matter during stability testing.
Class 2 medicine recallHigh riskMedicine · 15 Jul 2024
Sun Pharma UK Ltd is recalling certain batches as a precautionary measure due to a small number of leaks found intermittently in the infusion bags.
Class 2 medicine recallHigh riskMedicine · 4 Jul 2024
Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or…
Class 2 medicine recallHigh riskMedicine · 6 Jun 2024
Desitin Pharma UK Ltd is recalling all batches of Lamotrigine Desitin 10mg/ml Oral Suspension as a precautionary measure due to an out of specification observation in the appearance of samples during routine stability testing.…